MHRP and partners across four continents recently launched a new collaborative HIV cure research initiative called DELIVER, or Developing Leadership and Innovation in Viral Eradication Research.
MHRP, the KEMRI/Walter Reed Project, and local stakeholders have opened three community posts in outlying areas of Kericho, Kenya, to provide accessible, decentralized HIV prevention, care and treatment services under the President’s Emergency Plan for AIDS Relief (PEPFAR).
As countries progress towards meeting UNAIDS 95-95-95 targets for HIV diagnosis, treatment and viral suppression, PEPFAR service implementers are approaching the “last mile” of identifying missing cases and new infections in the most hard-to-reach populations. MHRP’s PEPFAR implementing partners in Kenya’s South Rift Valley (SRV) led the country in identifying individuals living with HIV and getting them on treatment, according to 2023 4th quarter performance data.
MHRP is partnering with the Makerere University Walter Reed Project (MUWRP) in Uganda to conduct a novel HIV vaccine study called “RapidVax,” which recently started in March 2024. This study (RV591) combines experimental HIV vaccines with a novel dose escalation strategy with the goal of improving the body’s immune response.
MHRP, through an international collaboration, just launched a new study (RV584) in Tanzania to test novel long-acting bispecific antibody alone and in combination with another potent monoclonal antibody (mAb) to determine and compare safety and antiviral effects, or how effective these drugs are at reducing the amount of HIV in people living with HIV, both alone and in combination.
